IFNG and lupus nephritis: With these antibodies, we analyzed IFN-γ cleavage status in five healthy subjects and five active (A) patients with SLE Stage III-(A) (n = 3) or Stage IV-(A) (n = 2) lupus nephritis (Fig. 7b, Supplementary Fig. 12 and Supplementary Table 1).